Pseudo-Complementary DNA
Pseudo-Complementary DNA
批准号:
8072639
负责人:
Howard Byron Gamper
金额:
$19.36万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-14 至 2012-08-29
关键词:
2,6-Diaminopurine2-thiothymineAddressAllelesApplications GrantsBase PairingBiological AssayComplementary DNADNADNA LigationDNA ResequencingDNA biosynthesisDNA-Directed DNA PolymeraseDetectionDevelopmentDiagnosticElementsEmerging TechnologiesFree EnergyGenesGrantHigher Order Chromatin StructureHumanHybridsLengthLibrariesLigationMethodsNanotechnologyNucleic AcidsNucleotidesOligonucleotide MicroarraysOligonucleotide ProbesOligonucleotidesPerformancePharmacogeneticsPlayPoint MutationPolymersPopulationPreparationPrimer ExtensionPropertyProtocols documentationRNAResearchReverse TranscriptionRoleSamplingSingle Nucleotide PolymorphismSingle-Stranded DNASolutionsSpecificityStructureTechnologyTemperatureTestingThermodynamicsTimeTranscriptWorkanalogbasecost effectivedesignimprovedmeltingnanoporenew technologynovelnovel strategiesprogramspublic health relevanceresearch studythree dimensional structuretripolyphosphate
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Conceptually, pseudo-complementary DNA (pcDNA) is a "structure-free" polymer composed of base analogs that don't interact with each other but are able to Watson-Crick pair to regular bases in a complementary probe. Base pairs in the resulting hybrids are composed of unique combinations of modified and natural nucleotides. The ability to convert native DNA or RNA into structure-free pcDNA would significantly improve the reliability and efficiency of short probes by eliminating interference from secondary structure in the target. The exquisite ability of such probes to discriminate against mismatches favors their use in the direct detection of single nucleotide polymorphisms. pcDNA targets would also facilitate the practical use of universal oligonucleotide microarrays and the development of extremely dense SNP microarrays. High throughput sequencing technologies based on oligonucleotide ligation or passage through a nanopore would also benefit. Recently, we developed a set of dNTP analogs that support enzymatic synthesis of DNA with reduced secondary structure and increased accessibility to short unmodified probes. In this grant application we propose to optimize methods for the preparation of pcDNA and to rigorously characterize the hybridization properties of this DNA with respect to accessibility, stability and specificity. Significant effort will be expended in developing a new, rapid and cost-effective approach to determining nearest neighbor free energies for both pairing and mis-pairing of novel bases such as the ones used to prepare pcDNA. This approach will use a microarray platform to simultaneously determine the melting profiles of hundreds of short duplexes. Successful completion of this research program will provide a comprehensive analysis of the practicality and benefits of pseudo-complemementary nucleic acids and establish whether microarrays can be used to simplify and accelerate the acquisition of free energy parameters for hybridization.
PUBLIC HEALTH RELEVANCE: Short pieces of nucleic acid known as oligonucleotides have applications in human diagnostics, pharmacogenetics and high throughput sequencing due to their ability to interact with DNA and RNA. Unfortunately, the performance of oligonucleotides is impaired by the presence of higher order structure in naturally occurring DNA and RNA. In this grant we will evaluate a novel strategy for eliminating higher order structure in DNA thereby improving the utility of oligonucleotides for both new and existing applications. In reducing the technology to practice, we will test a new microarray based strategy for acquiring the thermodynamic parameters that describe the interaction of oligonucleotides with "structure-free" DNA. This thermodynamic library will facilitate use of the new technology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pseudo-Complementary DNA
-
批准号:7871949
-
项目类别:
-
资助金额:$23.2万
-
财政年份:2010
-
负责人:Howard Byron Gamper
-
依托单位: